絞り込み

16644

広告

Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.

著者 Malec K , Broniatowska E , Undas A
Lupus.2019 Nov 22 ; ():961203319889156.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (12view , 0users)

Full Text Sources

Miscellaneous

Despite controversies, direct oral anticoagulants (DOACs) are increasingly used in antiphospholipid syndrome (APS). We investigated the safety and efficacy of DOACs versus vitamin K antagonists (VKAs) in real-life consecutive APS patients.
PMID: 31757182 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード